menu
    • menu

    Company profile for AusperBio

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AusperBio is a clinical-stage biopharmaceutical company with operations in China and the USA, dedicated to the development of innovative, best-in-class therapeutics for curing HBV infections. The company's mission is to become a world leader in antiviral therapeutics. The company has developed a proprietary ASO technology platform, which enables effective and potent targeted therapies for liver diseases, with the potential for...
    AusperBio is a clinical-stage biopharmaceutical company with operations in China and the USA, dedicated to the development of innovative, best-in-class therapeutics for curing HBV infections. The company's mission is to become a world leader in antiviral therapeutics. The company has developed a proprietary ASO technology platform, which enables effective and potent targeted therapies for liver diseases, with the potential for expansion into new target areas beyond the liver. AusperBio's strategy is to combine its leading oligonucleotide therapies with therapeutic antibodies and mRNA vaccines to address a broad range of unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AusperBioChina Flag
    Country
    Country
    China
    Address
    Address
    Room 2501, 25th Floor, Building 5, No. 688, Bin'an Road Changhe Street, Binjia...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ausperbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ausperbio Finishes Phase III AUSHINE Study Enrollment
    Ausperbio Finishes Phase III AUSHINE Study Enrollment

    22 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/ausperbio-completes-patient-enrollment-in-phase-iii-aushine-study-of-ahb-137-for-chronic-hepatitis-b-302647929.html

    PR NEWSWIRE BIO
    22 Dec 2025
    Share Share
    AusperBio Announces AHB-137 Monotherapy Achieved 30% Cure Rate
    AusperBio Announces AHB-137 Monotherapy Achieved 30% Cure Rate

    12 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/ausperbio-announces-ahb-137-monotherapy-achieved-30-functional-cure-rate-in-hbe-negative-chb-patients-on-stable-nucleostide-analogue-na-therapy-302640217.html

    PR NEWSWIRE BIO
    12 Dec 2025
    Share Share
    Ausperbio Unveils AHB-137 48-Week Phase II Results In Chronic
    Ausperbio Unveils AHB-137 48-Week Phase II Results In Chronic

    08 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ausperbio-announces-late-breaking-48-week-phase-ii-data-of-ahb-137-in-chronic-hepatitis-b-at-aasld-2025-302609280.html

    PR NEWSWIRE
    08 Nov 2025
    Share Share
    AusperBio Secures $63M in Series B2 Funding for Hepatitis B Cure
    AusperBio Secures $63M in Series B2 Funding for Hepatitis B Cure

    21 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ausperbio-raises-63-million-in-series-b2-financing-to-accelerate-functional-cure-therapies-for-chronic-hepatitis-b-302562432.html

    PR NEWSWIRE
    21 Sep 2025
    Share Share
    AusperBio Finishes Enrolling in 2 Ph II Trials of AHB-137
    AusperBio Finishes Enrolling in 2 Ph II Trials of AHB-137

    18 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ausperbio-completes-enrollment-in-two-phase-ii-clinical-trials-of-ahb-137-for-chronic-hepatitis-b-302561157.html

    PR NEWSWIRE
    18 Sep 2025
    Share Share
    AusperBio Gets China CDE Nod for AHB-137 Ph III Trial
    AusperBio Gets China CDE Nod for AHB-137 Ph III Trial

    21 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ausperbio-receives-china-cde-clearance-to-advance-ahb-137-into-phase-iii-clinical-trial-for-chronic-hepatitis-b-302509921.html

    PR NEWSWIRE
    21 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search